RXST · RxSight, Inc.
$6.13
+0.08 (+1.32%)
At close · Jul 29
Market Cap
$250.45M
Shares
41.40M
RxSight, Inc. Earnings Call Transcripts
Every quarterly earnings call for RxSight, Inc. (RXST) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲90.9%
$16.09M
−$15.61M
'22 Q4
23-01-09
▲95.6%
$17.49M
−$13.21M
'23 Q1
23-05-09
▲83.2%
$20.81M
−$13.80M
'23 Q2
23-08-07
▲76%
$22.20M
−$12.41M
'23 Q3
23-11-09
▲77.6%
$28.58M
−$9.18M
'23 Q4
24-02-28
▲68.7%
$29.51M
−$9.10M
'24 Q1
24-05-06
▲67.6%
$34.89M
−$6.08M
'24 Q2
24-08-05
▲59.1%
$35.31M
−$6.34M
'24 Q3
24-11-07
▲40.7%
$40.21M
−$5.94M
'24 Q4
25-02-25
▲28.4%
$37.90M
−$8.19M
'25 Q1
25-05-07
▼3.6%
$33.64M
−$11.79M
'25 Q2
25-07-08
▼14.1%
$30.34M
−$9.82M
'25 Q3
25-11-05
▼18.9%
$32.61M
−$9.15M
'25 Q4
26-02-25
LATEST
▼18.5%
$30.89M
−$15.88M
'26 Q1
26-05-06
Earnings call
FY26 · Q2
2026-08-05
RxSight Second Quarter 2026 Earnings Conference Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-07-07
RXST Conference Call
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-06
RxSight, Inc. Q2 FY2026 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
RxSight, Inc. Q1 FY2026 Earnings Call
Balanced tone
Customer reengagement programs
Stabilization of LAL volumes and utilization
Premium IOL market opportunity
Revenue
$30.89M
▼ 18.5% YoY Diluted EPS
$-0.38
Gross margin
76.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
RxSight, Inc. Q4 FY2025 Earnings Call
Balanced tone
LAL procedure volumes and revenue mix
LDD (capital equipment) placements and installed base
Gross margin pressure and inventory sell-through
Revenue
$32.61M*
▼ 18.9% YoY Gross margin
77.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-05
RxSight, Inc. Q3 FY2025 Earnings Call
Cautious tone
Gross Margin Expansion
Reimbursement Pressure
LDD Capital Equipment Weakness
Revenue
$30.34M
▼ 14.1% YoY Diluted EPS
$-0.24
Gross margin
79.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-08
RxSight, Inc. Q2 FY2025 Earnings Call
Cautious tone
LAL utilization and customer success reorganization
International expansion (OUS)
Operating expense growth and discipline
Revenue
$33.64M
▼ 3.6% YoY Diluted EPS
$-0.29
Gross margin
74.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
RxSight, Inc. Q1 FY2025 Earnings Call
Cautious tone
Soft premium IOL market and macro headwinds
LDD placements and installed base growth
Q1 revenue miss and same-store LAL decline
Revenue
$37.90M
▲ 28.4% YoY Diluted EPS
$-0.20
Gross margin
74.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
RxSight, Inc. Q4 FY2024 Earnings Call
Confident tone
LAL procedure volume growth
LDD installed base expansion
2025 financial guidance
Revenue
$40.21M*
▲ 40.7% YoY Gross margin
71.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
RxSight, Inc. Q3 FY2024 Earnings Call
Confident tone
LAL and LAL+ lens sales and utilization
LDD installed base growth and capital equipment placements
Seasonality and Q4 outlook
Revenue
$35.31M
▲ 59.1% YoY Diluted EPS
$-0.16
Gross margin
71.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-05
RxSight, Inc. Q2 FY2024 Earnings Call
Confident tone
Raised Full-Year 2024 Guidance
Operating Expense and Stock-Based Compensation Increase
Gross Margin Expansion
Revenue
$34.89M
▲ 67.6% YoY Diluted EPS
$-0.16
Gross margin
69.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
RxSight, Inc. Q1 FY2024 Earnings Call
Confident tone
LAL/LAL+ product momentum
Revenue and gross margin guidance raise
Installed base / LDD capital equipment
Revenue
$29.51M
▲ 68.7% YoY Diluted EPS
$-0.25
Gross margin
70.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
RxSight, Inc. Q4 FY2023 Earnings Call
Confident tone
LAL and LAL Plus adoption
Light Delivery Device (LDD) installed base growth
Revenue and procedure volume growth
Revenue
$28.58M*
▲ 77.6% YoY Gross margin
61.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-09
RxSight, Inc. Q3 FY2023 Earnings Call
Revenue
$22.20M
▲ 76% YoY Diluted EPS
$-0.35
Gross margin
61.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-07
RxSight, Inc. Q2 FY2023 Earnings Call
Revenue
$20.81M
▲ 83.2% YoY Diluted EPS
$-0.40
Gross margin
57.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
RxSight, Inc. Q1 FY2023 Earnings Call
Revenue
$17.49M
▲ 95.6% YoY Diluted EPS
$-0.42
Gross margin
59.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-09
RxSight, Inc. Q4 FY2022 Earnings Call
Revenue
$16.09M*
▲ 90.9% YoY Gross margin
46.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-07
RxSight, Inc. Q3 FY2022 Earnings Call
Revenue
$12.62M
▲ 118% YoY Diluted EPS
$-0.61
Gross margin
42.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
RxSight, Inc. Q2 FY2022 Earnings Call
Revenue
$11.36M
▲ 132% YoY Diluted EPS
$-0.61
Gross margin
42.1%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
RxSight, Inc. Q1 FY2022 Earnings Call
Revenue
$8.94M
▲ 156.7% YoY Diluted EPS
$-0.64
Gross margin
42.1%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-08
RxSight, Inc. Q4 FY2021 Earnings Call
Revenue
$8.43M*
Gross margin
34.0%
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-10
RxSight, Inc. Q3 FY2021 Earnings Call
Revenue
$5.79M
▲ 38.8% YoY Diluted EPS
$-0.68
Gross margin
23.2%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-09-09
RxSight, Inc. Q2 FY2021 Earnings Call
Revenue
$4.90M
▲ 81% YoY Diluted EPS
$-3.53
Gross margin
-16.6%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–23 of 23 earnings calls
Key facts
CIK
1111485
CUSIP
78349D107
13F (30d)
22 filings
22 filers
Visit website
Investor relations